The common pathogenetic feature appears to be the reduction/lack of CASQ2 since the CASQ2 null (KO) model is associated with the CPVT phenotype (Glukhov et al. 2015) . This evidence concerns the gene CASQ2 and catecholaminergic polymorphic ventricular tachycardia.